Skip to content
Atlas Research Compounds

The efficacy of Semax in the treatment of patients at different stages of ischemic stroke

A rehabilitation-stage comparison that followed 110 people after ischemic stroke and assessed plasma BDNF, motor performance, and Barthel index scores.

Indexed abstract extractedQuality: ModerateModerate confidence

Study metadata

Journal
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Publication year
2018
Study type
Human observational study
Species
Human
Evidence grade
Grade B
Extraction depth
Indexed abstract extracted
Study quality
Moderate
Confidence
Moderate confidence
Sample size
110

Structured extraction

Population
Human participants; population details require article-level extraction.
Intervention
Exposure or intervention details require abstract or full-text extraction before use.
Comparator
Not stated or not fully extracted from the indexed abstract.
Duration
Not stated or not fully extracted from the indexed abstract.
Primary endpoint
Primary outcome or association endpoint not fully extracted.
Secondary endpoints
No secondary endpoints extracted.
Funding source
Not stated in the indexed abstract.

Findings and extraction notes

  • The indexed abstract reports higher plasma BDNF and faster functional recovery in Semax-treated subgroups, alongside an independent association with earlier rehabilitation.

Limitations

  • The abstract describes treatment subgroups but does not establish randomized allocation or blinding.
  • The publication is in Russian and the indexed English abstract provides limited methodological detail.

Linked compounds